Home

CEVEC Pharmaceuticals is a leading provider of high-performance cell technology for the manufacturing of advanced biotherapeutics from R&D to manufacturing scale.

The company’s product portfolio comprises platform technologies for gene therapy viral vectors, viral vaccines, Exosomes and complex recombinant proteins. ELEVECTA® is specifically designed for AAV manufacturing, while CAP® addresses Adenoviral vectors, Lentiviral vectors, Oncolytic viruses and Exosomes. CAP®Go is the platform of choice for complex recombinant proteins.

STABLE AAV PRODUCER CELL LINES

VIRAL VECTORS, VACCINES AND EXOSOMES

GLYCO-OPTIMIZED PROTEINS

ASGCT 2021
Virtual Annual Meeting

May 11 – 14, 2021

OPEN POSITIONS (M/F/D)

• BUSINESS DEVELOPMENT MANAGER

• SCIENTIST CELL LINE DEVELOPMENT

• JUNIOR SCIENTIST IN UPSTREAM PROCESS DEVELOPMENT

• TECHNICAL ASSISTANT CELL LINE DEVELOPMENT

• TECHNICAL ASSISTANT VIRAL VECTORS

• LABORHILFE / LABORUNTERSTÜTZUNG

NEWSLETTER

Subscribe for the CEVEC Newsletter according to our Privacy Policy to receive the latest CEVEC News,
including Press Releases, Conference Information and Webinar Invitations.

© CEVEC Pharmaceuticals GmbH 2020